ScanSource (SCSC) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
20 Aug, 2026Strategic positioning and business model
Focused on technology distribution with $3.2B+ net sales, 25,000 channel partners, and 2,100 employees as of FY26.
Operates two segments: Specialty Technology Solutions (hardware-centric, 77% of gross profit) and Intelisys & Advisory (recurring revenue, 23% of gross profit).
Recurring revenue now accounts for 34% of gross profit, with a goal to reach 50% in three years.
Agency model in Intelisys & Advisory delivers 98% recurring revenue gross profit and high capital efficiency.
Strategic edge includes expertise in complex solutions, flexible go-to-market models, and broad supplier/channel access.
Financial performance and capital discipline
Gross margin expanded to 13.6% in FY26, with adjusted ROIC at 14.7%.
Net leverage ratio near zero; $98M in share repurchases in FY26.
Free cash flow conversion goal of 80%+ of non-GAAP net income annually.
Strong balance sheet with $400M revolver and $310M total liquidity as of June 2026.
Capital allocation prioritizes high-ROI investments, disciplined M&A, and shareholder returns.
Growth strategy and market drivers
Growth driven by cloud, SaaS, cybersecurity, AI, and digitization trends.
Recent acquisitions (e.g., MicroAge, resourcive, ADVANTIX, ZATAXOOM) expand capabilities and recurring revenue.
New converged communications business unit launched to accelerate recurring revenue and partner engagement.
Strategic M&A targets capital-light, high-margin, recurring revenue businesses.
Three-year goals: 5–7% gross profit CAGR, 50% recurring revenue GP, mid-teens adjusted EBITDA margin.
Latest events from ScanSource
- Strong Q4 and FY results, with MicroAge acquisition set to drive further margin and sales growth.SCSC
Q4 2026 - Recurring revenue and margin expansion drive growth, supported by disciplined capital allocation.SCSC
Investor presentation - Quarterly sales up 8.8% to $766.8M, strong cash flow, margin gains, and new business initiatives.SCSC
Q3 2026 - Recurring revenues and disciplined capital allocation drive margin growth and efficiency.SCSC
47th Annual Raymond James Institutional Investor Conference - Q2 FY26 saw 2.5% sales growth, margin pressure, and reduced full-year guidance.SCSC
Q2 2026 - Hybrid distribution and recurring revenue drive growth, with a focus on cash flow and strategic M&A.SCSC
Raymond James 2024 TMT & Consumer Conference - Recurring revenue and margin gains offset sales decline; FY25 outlook reaffirmed.SCSC
Q1 2025 - Sales fell but margins and cash flow improved; acquisitions and hybrid strategy support growth.SCSC
Q4 2024 - Sales fell 15.5% but margin and recurring revenue rose; FY25 guidance reaffirmed.SCSC
Q2 2025